Viewing Study NCT06892002


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-26 @ 2:23 AM
Study NCT ID: NCT06892002
Status: COMPLETED
Last Update Posted: 2025-08-15
First Post: 2025-01-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Description of Patients With Type 1 Diabetes Treated With Teplizumab
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module